Troglitazone Attenuates TGF-β1-Induced EMT in Alveolar Epithelial Cells via a PPARγ-Independent Mechanism

The Antifibrogenic Potential of PPARγ Ligands in Pulmonary Fibrosis

(2016) Patricia J. Sime   JOURNAL OF INVESTIGATIVE MEDICINE

Interactions Between β-Catenin and Transforming Growth Factor-β Signaling Pathways Mediate Epithelial-Mesenchymal Transition and Are Dependent on the Transcriptional Co-activator cAMP-response Element-binding Protein (CREB)-binding Protein (CBP)

(2012) Beiyun Zhou et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

PPAR-γ Ligands Repress TGFβ-Induced Myofibroblast Differentiation by Targeting the PI3K/Akt Pathway: Implications for Therapy of Fibrosis

(2011) Ajit A. Kulkarni et al.   PLoS One

Repression of β-catenin signaling by PPARγ ligands

(2010) Desheng Lu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Peroxisome Proliferator-Activated Receptor-  Activation Inhibits Tumor Metastasis by Antagonizing Smad3-Mediated Epithelial-Mesenchymal Transition

(2010) A. K. Reka et al.   MOLECULAR CANCER THERAPEUTICS

Electrophilic Peroxisome Proliferator–Activated Receptor-γ Ligands Have Potent Antifibrotic Effects in Human Lung Fibroblasts

(2009) Heather E. Ferguson et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Update in idiopathic pulmonary fibrosis

(2009) Stephen K Frankel et al.   CURRENT OPINION IN PULMONARY MEDICINE

Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition

(2009) Marcello Guarino et al.   HUMAN PATHOLOGY

Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells

(2009) Kyoung-Ok Hong et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ-INDEPENDENT EFFECTS OF THIAZOLIDINEDIONES ON HUMAN CARDIAC MYOFIBROBLAST FUNCTION

(2008) Romana S Mughal et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma Ligand, Suppresses Bleomycin-Induced Acute Lung Injury and Fibrosis

(2008) Yasuhiro Aoki et al.   RESPIRATION

Review: Therapies for interstitial lung disease: past, present and future

(2008) Robert Kim et al.   Therapeutic Advances in Respiratory Disease

PPAR-γ agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis

(2007) Jami E. Milam et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY